
About Guardion Health Sciences
Guardion Health Sciences is a publicly listed company based in San Diego (United States) founded in 2009. Guardion Health Sciences has raised $11.14 million across 11 funding rounds from investors including Liaison Interactive and America’s Seed Fund. The company has 12 employees. Guardion Health Sciences has completed 2 acquisitions, including VectorVision and Viactiv. Its chief executive, as recorded, is Michael Favish. Guardion Health Sciences offers products and services including Dietary Supplements and Clinically Supported Products. Its focus areas include Traditional Nutraceuticals and Diversified. Its legal entity is Guardion Health Sciences, Inc.
Company details
Developer of clinically supported dietary supplements for ocular health. It develops and markets dietary supplements specifically focused on improving eye health. The products are designed to address specific consumer needs within the ocular health market and are based on clinical research and evidence. The companys mission is to provide effective nutritional solutions to help maintain eye health and overall well-being. The supplements are intended to be used as part of a broader health strategy.
- Headquarters San Diego, United States
- Employees 12
- Stage Public
- SectorsHealthcare
- Email••••••••
- Website guardionhealth.com
- Social LinkedIn X Facebook
- Legal Name Guardion Health Sciences, Inc
- Annual Revenue$12.25 M (USD)11as on Dec 31, 2023
- Net Profit$158.03 K (USD)101as on Dec 31, 2023
- EBITDA-$4.34 M (USD)75as on Dec 31, 2023
- Total Equity Funding$11.14M (USD)
in 11 rounds
- Latest Funding Round$999.69K (USD), Grant
Aug 2020
- InvestorsLiaison Interactive
& 1 more
- Employee Count12
- Investments & AcquisitionsVectorVision
& 1 more
Products & Services of Guardion Health Sciences
Guardion Health Sciences offers a comprehensive portfolio of products and services, including Dietary Supplements and Clinically Supported Products.
Dietary supplements for ocular health are developed to support benefits related to eye conditions and active lifestyles
Products that are clinically supported and aimed at addressing nutrient gaps in metabolic processes are offered by Guardion Health Sciences
Funding Insights of Guardion Health Sciences
Guardion Health Sciences has successfully raised a total of $11.14M across 11 strategic funding rounds. The most recent funding activity was a Grant round of $999.69 thousand completed in August 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $11.14M
- Total Rounds 11
- Last Round Grant — $999,687
- First Round $500,000
(May 2015)
- Investors Count 2
Latest 10 of 11 funding rounds of Guardion Health Sciences with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2020 | $999,687 | Grant | – | – | |
| Mar 2020 | $3.51M | Post-IPO | – | – | – |
| Apr 2019 | $350,000 | Series B | – | – | – |
| Feb 2019 | $223,660 | Grant | – | – | |
| Jan 2019 | $850,000 | Series B | – | – | – |
| Jan 2018 | $5M | Series B | – | – | |
| Jul 2017 | $3.11M | Series B | – | – | – |
| Mar 2017 | $50,000 | Series A | – | – | – |
| Jan 2017 | $1.71M | Series A | – | – | – |
| Mar 2016 | $76,000 | Seed | – | – | – |
2 investors in total: 2 institutional.
Investors in Guardion Health Sciences
Guardion Health Sciences has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Liaison Interactive and America’s Seed Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital fund backed by the US Government | seedfund.nsf.gov | Alexandria, United States | ||
Provider of integrated media and entertainment services | 2007 | lianluo.com | Hangzhou, China |
Investor details for Guardion Health Sciences
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Guardion Health Sciences
5 people are tracked at Guardion Health Sciences (2 in leadership, 3 in board & advisors); the tracked headcount is 12.
| Name | Role | Group |
|---|---|---|
Michael Favish | CEO & President | Leadership |
Susan Klein | Director, Medical Education | Leadership |
Donald A. Gagliano | Director | Board & advisors |
Mark Goldstone | Director | Board & advisors |
Robert N. Weingarten | Director | Board & advisors |
Complete people profiles for Guardion Health Sciences
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Guardion Health Sciences
Guardion Health Sciences has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include VectorVision and Viactiv.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Manufacturer of calcium and omega-3 supplements in chewable and gummy forms | viactiv.com | Greenwich, United States | 2012 | May 2021 | $26M | |
Vision testing technology is provided through specialized instruments. | vectorvision.com | Greenville, United States | 1987 | Mar 2017 | •••• |
Complete acquisition details for Guardion Health Sciences
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Guardion Health Sciences
6 dated milestones of Guardion Health Sciences across 12 years, from founding to its latest funding, stage changes and deals.
- Founded Guardion Health Sciences is founded.
- Funding First funding round of $500K.
- Acquisition Acquires VectorVision.
- IPO Lists on the stock exchange (IPO).
- Funding Latest funding round, Grant, of $1,000K.
- Acquisition Acquires Viactiv.
Web traffic of Guardion Health Sciences
The website of Guardion Health Sciences (guardionhealth.com) receives about 1.2K visits a month.
- Monthly visits1.2K
Top companies in Traditional Health & Nutrition
3 companies that operate in the same segment as Guardion Health Sciences (Traditional Health & Nutrition) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Manufacturer of generics formulations | 2002 | Bridgewater, New Jersey, United States | USD 3.02 B | 8,300 | ||
Biosimilar therapeutics are developed for oncology and autoimmune diseases. | 2010 | Redwood City, California, United States | USD 143.62 M | USD 42.17 M | 228 | |
Ophthalmic pharmaceuticals and instruments are developed for eye care. | 1853 | Bridgewater, New Jersey, United States | USD 5.1 B | 13,500 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Guardion Health Sciences
Guardion Health Sciences was founded in 2009 and raised its 1st funding round 6 years after it was founded.
Guardion Health Sciences is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Michael Favish is the CEO of Guardion Health Sciences, as recorded in our data.
Guardion Health Sciences is a funded company, having raised a total of $11.14M across 11 funding rounds to date. The company's 1st funding round was a Seed of $76K, raised on May 2015.
Guardion Health Sciences has 12 employees.
Annual revenue of Guardion Health Sciences is $12.25M as on Dec 31, 2023.
Developer of clinically supported dietary supplements for ocular health. It develops and markets dietary supplements specifically focused on improving eye health. The products are designed to address specific consumer needs within the ocular health market and are based on clinical research and evidence. The companys mission is to provide effective nutritional solutions to help maintain eye health and overall well-being. The supplements are intended to be used as part of a broader health strategy.
Guardion Health Sciences offers Dietary Supplements and Clinically Supported Products.
Guardion Health Sciences has made 2 acquisitions, including VectorVision, and Viactiv.
Guardion Health Sciences has 2 investors. Key investors include Liaison Interactive, and America’s Seed Fund.
Guardion Health Sciences operates through Guardion Health Sciences, Inc.